Portfolio company
Hologenomix
Netherlands · £298k raised
Raised
£298k
Latest stage
Pre-seed
Rounds recorded
2 · 1 undisclosed
Backed by
2 investors
Sectors
About
Hologenomix develops an extraction platform for isolating cell-free nucleic acids from biofluids to provide liquid biopsy and molecular diagnostic services to research and healthcare institutions.
SourceFunding history · 2
Similar companies
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
BioCaptiva
BioCaptiva develops polymer-based medical devices for capturing cell-free DNA from biological fluids for use by diagnostic laboratories, biotechnology companies, and healthcare providers.
Enumera Molecular
The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Flomics
Flomics develops liquid biopsy blood tests and a bioinformatics platform for early cancer detection in clinical and research settings.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
